FME.DE
Fresenius Medical Care AG I
XETRAEUREQUITY
Healthcare
DELAYED
Last price
40.14
▼ 0.75 (1.83%)
MARKET · —
Price
Open
40.56
Prev close
40.89
Day high
40.70
Day low
40.09
Volume
1.08M
Market cap
$10.68B
P/E (TTM)
11.88
52W range
34.57 – 47.86
Trailing performance
Returnvs SPY
1W
-2.19%
-0.8%
1M
-6.63%
-10.4%
3M
+7.59%
+4.5%
6M
-3.02%
-14.1%
YTD
-1.52%
-13.8%
1Y
-7.94%
-27.9%
3Y
-10.26%
-84.4%
5Y
-35.03%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$10.68B
Enterprise value$21.57B
Revenue (TTM)$19.43B
Gross profit$5.12B
EBITDA$2.72B
Net income$937.78M
EPS (TTM)$3.38
Free cash flow$2.02B
Total cash$1.06B
Total debt$10.98B
Book value / share$47.19
Shares outstanding266.11M
Float181.89M
Short % of float—
Dividend yield3.71%
Beta (5Y)0.84
Valuation & profitability ratios
Trailing P/E11.88
Forward P/E9.26
PEG ratio0.82
Price / sales—
Price / book0.85
EV / revenue1.11
EV / EBITDA7.93
Gross margin26.35%
Operating margin10.77%
Profit margin4.83%
Return on equity8.52%
Return on assets3.98%
Debt / equity81.13
Current ratio1.07
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $19.63B | $19.34B | $19.45B | $19.40B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $978.00M | $538.00M | $499.00M | $673.40M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $978.00M | $538.00M | $499.00M | $673.40M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.07 | 1.13 | +5.8% |
| Mar 2026 | 1.05 | 0.91 | -12.9% |
| Dec 2025 | 1.08 | 1.44 | +33.4% |
| Sep 2025 | 1.04 | 1.10 | +5.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.04 | 4 | $4.96B | +1.5% |
| Next quarter | 0.93 | 4 | $5.10B | +0.6% |
| Current year | 4.05 | 14 | $19.56B | -0.4% |
| Next year | 4.34 | 15 | $20.22B | +3.4% |
Analyst targets & ownership
Mean target$42.80
High target$67.00
Low target$30.00
Implied upside6.63%
Analyst count17
ConsensusHOLD
Strong buy / Buy1 / 3
Hold7
Sell / Strong sell3 / 3
Held by insiders28.60%
Held by institutions49.29%
Institutions holding370
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
76.11M
Total on file
Moving averages & technicals
SMA 10
41.06
-2.25% from price
SMA 20
42.08
-4.62% from price
SMA 50
41.81
-3.99% from price
SMA 100
40.00
+0.36% from price
SMA 200
39.82
+0.80% from price
EMA 12
41.20
-2.57% from price
EMA 26
41.60
-3.52% from price
EMA 50
41.33
-2.89% from price
RSI (14)
36.9
Neutral
MACD (12,26,9)
-0.41
Hist -0.26
ATR (14)
1.07
2.67% of price
Realised vol 30D
28.6%
Annualised
Bollinger upper
44.90
20, 2σ
Bollinger lower
39.26
20, 2σ
50 / 200 cross
Golden
41.81 vs 39.82
Trend bias
Above 200
+0.80%
Risk profile
Beta vs SPY
-0.02
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
28.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-26.9%
Peak to trough
Max drawdown 5Y
-61.9%
Peak to trough
ATR 14
1.07
2.67% of price
Beta (reported)
0.84
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Government of Canada announces Peter Ballantyne Cree Nation as an Indigenous Skills and Employment Training Program agreement holder
CNW Group · 15m ago
Apple Announced Its Largest-Ever Stock Buyback Under Tim Cook's Leadership. Here's Why the Size of the Repurchase Program Matters for Shareholders.
Motley Fool · 17m ago
Wyndham Clark surges clear at BMW Championship
AFP · 18m ago
Up 20% in 1 Day, is Hyperliquid Worth Buying Hand Over Fist Right Now?
Motley Fool · 20m ago
Ken de la Bastide column: Residents will be dealing with flooding for years
The Herald Bulletin, Anderson, Ind. · 20m ago
Real Madrid snatch late win at Espanyol on Mourinho's return
AFP · 20m ago
Inter thrash Monza to launch Serie A title defence
AFP · 21m ago
Amazon's $212 Seiko luxury watch proves every collector needs a chronograph
TheStreet · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.